Aljian Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Aljian Capital Management, LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $15.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$15.3M
| Company | Shares | Value |
|---|---|---|
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 12,146 | $3.3M |
| AMGNAMGEN INC | 5,713 | $2.0M |
| LLYELI LILLY & Co | 1,811 | $1.7M |
| ABBVAbbVie Inc. | 7,000 | $1.5M |
| PMPhilip Morris International Inc | 8,396 | $1.4M |
| BMYBRISTOL MYERS SQUIBB CO | 17,481 | $1.1M |
| JNJJOHNSON & JOHNSON | 3,407 | $833K |
| MRKMerck & Co., Inc. | 5,971 | $718K |
| GEHCGE HealthCare Technologies Inc. | 8,866 | $631K |
| GILDGILEAD SCIENCES, INC. | 4,514 | $629K |
| ELVElevance Health Inc. | 2,066 | $605K |
| ABTABBOTT LABORATORIES | 5,199 | $534K |
| BIIBBIOGEN INC. | 2,540 | $466K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.